Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Technical Aspects and Difficulties in the Management of Head and Neck Cutaneous Malignancies in Xeroderma Pigmentosum

  • Sibar, Serhat (Department of Plastic, Reconstructive and Aesthetic Surgery, Gazi University Hospital) ;
  • Findikcioglu, Kemal (Department of Plastic, Reconstructive and Aesthetic Surgery, Gazi University Hospital) ;
  • Erdal, Ayhan Isik (Department of Plastic, Reconstructive and Aesthetic Surgery, Gazi University Hospital) ;
  • Barut, Ismail (Department of Plastic, Reconstructive and Aesthetic Surgery, Gazi University Hospital) ;
  • Ozmen, Selahattin (Department of Plastic, Reconstructive and Aesthetic Surgery, Koc University Hospital)
  • Received : 2016.02.07
  • Accepted : 2016.06.07
  • Published : 2016.07.20
Download PDF
⟨ Previous Next ⟩

Abstract

Background Xeroderma pigmentosum (XP) is an autosomal recessive disorder characterized by xerosis, ultraviolet light sensitivity, and cutaneous dyspigmentation. Due to defects in their DNA repair mechanism, genetic mutations and carcinogenesis inevitably occurs in almost all patients. In these patients, reconstruction of cutaneous malignancies in the head and neck area is associated with some challenges such as likelihood of recurrence and an aggressive clinical course. The aim of this study is to discuss the therapeutic options and challenges commonly seen during the course of treatment. Methods Between 2005 and 2015, 11 XP patients with head and neck cutaneous malignancies were included in this study. Demographic data and treatment options of the patients were evaluated. Results The mean age of the patients was 32 years (range, 10-43) (4 males, 7 females). The most common tumor type and location were squamous cell carcinoma (6 patients) and the orbital region (4 patients), respectively. Free tissue transfer was the most commonly performed surgical intervention (4 patients). The average number of surgical procedures was 5.5 (range, 1-25). Six patients were siblings with each other, 5 patients had local recurrences, and one patient was lost to follow-up. Conclusions Although genetic components of the disease have been elucidated, there is no definitive treatment algorithm. Early surgical intervention and close follow-up are the gold standard modalities due to the tendency toward rapid tumor growth and possible recurrence. Treatment must be individualized for each patient. In addition, the psychological aspect of the disease is an important issue for both patients and families.

Keywords

References

  1. Braun-Falco O. Dermatology. Berlin: Springer; 2000.
  2. Kraemer KH. Heritable diseases with increased sensitivity to cellular injury. In: Freedberg IM, Fitzpatrick TB, editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill, Health Professions Division; 1999. p.1848-62.
  3. Gard D. Nonpigmented premalignant lesions of the skin. Clin Plast Surg 1987;14:413-23.
  4. Bernerd F, Asselineau D, Frechet M, et al. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light. Photochem Photobiol 2005;81:19-24. https://doi.org/10.1562/2004-07-29-IR-250.1
  5. Hebra F, Kaposi M. On diseases of the skin including exanthemata. New Sydenham Soc 1874;61:252-8.
  6. de Laat WL, Jaspers NG, Hoeijmakers JH. Molecular mechanism of nucleotide excision repair. Genes Dev 1999;13:768-85. https://doi.org/10.1101/gad.13.7.768
  7. Berneburg M, Lehmann AR. Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Adv Genet 2001;43:71-102.
  8. Kilic S. Kseroderma pigmentozum. Guncel Pediatri 2004;2: 138-40.
  9. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum: cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 1987;123:241-50. https://doi.org/10.1001/archderm.1987.01660260111026
  10. Robbins JH, Kraemer KH, Lutzner MA, et al. Xeroderma pigmentosum: an inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med 1974;80:221-48. https://doi.org/10.7326/0003-4819-80-2-221
  11. Kraemer KH, Patronas NJ, Schiffmann R, et al. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 2007;145:1388-96. https://doi.org/10.1016/j.neuroscience.2006.12.020
  12. Rapin I, Lindenbaum Y, Dickson DW, et al. Cockayne syndrome and xeroderma pigmentosum. Neurology 2000;55: 1442-9. https://doi.org/10.1212/WNL.55.10.1442
  13. Lasso JM, Yordanov YP, Pinilla C, et al. Invasive basal cell carcinoma in a xeroderma pigmentosum patient: facing secondary and tertiary aggressive recurrences. J Craniofac Surg 2014;25:e336-8. https://doi.org/10.1097/SCS.0000000000000596
  14. Ozmen S, Uygur S, Eryilmaz T, et al. Facial resurfacing with a monoblock full-thickness skin graft after multiple malignant melanomas excision in xeroderma pigmentosum. J Craniofac Surg 2012;23:1542-3. https://doi.org/10.1097/SCS.0b013e31824e660e
  15. Atabay K, Celebi C, Cenetoglu S, et al. Facial resurfacing in xeroderma pigmentosum with monoblock full-thickness skin graft. Plast Reconstr Surg 1991;87:1121-5. https://doi.org/10.1097/00006534-199106000-00018
  16. Ergun SS, Cek DI, Demirkesen C. Is facial resurfacing with monobloc full-thickness skin graft a remedy in xeroderma pigmentosum? Plast Reconstr Surg 2002;110:1290-3. https://doi.org/10.1097/00006534-200210000-00012
  17. Aslan G, Karacal N, Gorgu M. New tumor formation on split-thickness skin grafted areas in xeroderma pigmentosum. Ann Plast Surg 1999;43:657-60. https://doi.org/10.1097/00000637-199912000-00015
  18. Elcin G. How to perform Mohs micrographic surgery? Arch Turkish Dermatol Venerol 2015;49:238-45.
  19. Elcin G. Mohs micrographic surgery: what if there is no Mohs micrographic surgery in Turkey? Arch Turkish Dermatol Venerol 2015;49:236-7.
  20. Schaffer JV, Orlow SJ. Radiation therapy for high-risk squamous cell carcinomas in patients with xeroderma pigmentosum: report of two cases and review of the literature. Dermatology 2011;223:97-103. https://doi.org/10.1159/000324509
  21. DiGiovanna JJ, Patronas N, Katz D, et al. Xeroderma pigmentosum: spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy. J Cutan Med Surg 1998;2: 153-8. https://doi.org/10.1177/120347549800200308
  22. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004;73:39-85. https://doi.org/10.1146/annurev.biochem.73.011303.073723
  23. Lambert WC, Lambert MW. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum. Photochem Photobiol 2015;91:475-83. https://doi.org/10.1111/php.12385
  24. Kocabalkan O, Ozgur F, Erk Y, et al. Malignant melanoma in xeroderma pigmentosum patients: report of five cases. Eur J Surg Oncol 1997;23:43-7. https://doi.org/10.1016/S0748-7983(97)80141-2

Cited by

  1. Severe Facial-Disfiguring Xeroderma Pigmentosum With Rapidly Progressing Malignant Tumors vol.145, pp.2, 2016, https://doi.org/10.1001/jamaoto.2018.3218
  2. 색소피부건조증 환자에서 발생한 안면부 기저세포암의 치료 증례 보고 vol.36, pp.1, 2016, https://doi.org/10.21593/kjhno/2020.36.1.39